文章核心观点 公司PROACTIS SA董事会任命Andrew REARDON为董事替代辞职的Adrian MCSHANE - CHAPMAN，该任命待下一次年度股东大会批准 [2]。 公司人事变动 - 6月25日公司董事会任命Andrew REARDON为董事替代辞职的Adrian MCSHANE - CHAPMAN，任命需在下次年度股东大会批准 [2] - Andrew Reardon于2025年1月加入Proactis集团任首席运营官，有运营领导、变革管理、项目管理和营收增长项目等领域经验 [3] 公司董事会组成 | 成员 | 职能 | 任期到期日期 | | --- | --- | --- | | Stephen LINE | 董事会主席兼首席执行官 | 2028年1月31日财年财务报表批准的年度股东大会 | | Lucy FOX | 董事 | 2028年1月31日财年财务报表批准的年度股东大会 | | Bonnie MITCHELL | 董事 | 2030年1月31日财年财务报表批准的年度股东大会 | | Andrew REARDON | 董事 | 2028年1月31日财年财务报表批准的年度股东大会 | [3]

COMBINED GENERAL MEETINGOF JULY 22, 2025 CONDITIONS FOR OBTAINING THE PREPARATORY DOCUMENTS Bernin (Grenoble), France, on July 1, 2025 - Soitec (Euronext Paris) reminds that the Company’s shareholders are invited to attend the Annual General Meeting to be held on Tuesday July 22, 2025 at 9:30 a.m. (Paris time), in the Auditorium of the VERSO conference Center located at 52 rue de la Victoire, 75009 Paris, France. The preliminary meeting notice serving as convening notice as provided for in Article R. 225-73 ...

Bollène (France), July 1st, 2025 – 06 :00pm (CET)Press Release Return to normal trading onEuronext Growth Paris™ Exit from the "Penalty Bench" compartment as of July 2nd, 2025 Egide Group (Euronext Growth Paris™- ISIN: FR0000072373 - Ticker: ALGID), worldwide provider of hermetic packages and connectors and heat dissipation solutions for sensitive electronic components, announces that its shares will return to normal trading as of July 2nd, 2025. Following the publication of its 2024 Annual Financial Report ...

Aggregated presentation by day and by market Statement of transactions in own shares from June 23rd to June 27th 2025 Name of the issuer Identity code of the issuer (Legal Entity Identifier) Day of the transaction Identity code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) IPSEN 549300M6SGDPB4Z94P11 23/06/2025 FR0010259150 335 100,58955 AQEU IPSEN 549300M6SGDPB4Z94P11 23/06/2025 FR0010259150 ...

Quarterly financial information – Neuilly-sur-Seine, Tuesday, July 1, 2025 – 5.45 pm Rental income up +8% in the 1st half of 2025 Rental income (IFRS) at June 30, 2025 (non-audited figures) € million Year 2025 Year 2024 Trends 1st quarter (Jan. - March) 52.9 48.1 +10% 2nd quarter (April - June) 52.9 50.0 +6% Total 1st half 105.8 <td style="width:113.4px;;text-align: center ; vertical-align: middle; border-top: solid ...

- Attachment Detailed information on share buyback transactions on June 24, 2025 ...

Eurobio Scientific completes the acquisition of Life Science unit of Voden Medical Instruments Spa in Italy Paris, July 1st, 2025 Eurobio Scientific (FR0013240934, ALERS), (FR0013240934, ALERS, PEA-PME eligible), a leading French group in in vitro specialty medical diagnostics and life sciences, today announces the completion of the acquisition of the assets of the Life Science unit of Voden Medical Instruments Spa1. The unit focuses on diagnostics, cellular and molecular biology as well as genome analysis ...

Press ReleaseJuly 1, 2025 Renault S.A.: disclosure of trading in own shares on June 24, 2025 Boulogne-Billancourt, July 1, 2025 In accordance with applicable regulations relating to share buybacks, Renault S.A. hereby declares the buyback of its own shares carried out on June 24, 2025, under the mandate given to an investment services provider for the acquisition of a maximum number of 300,000 Renault shares. The purpose of such share buyback is to cover Renault Group's obligations in the context of t ...

Nanterre, June 30th, 2025 Disclosure of transactions in on shares from June 23rd to June 27th,2025 Within the framework of the authorization granted by the General Meeting of VINCI SA of April 17th, 2025, to trade in its shares and in accordance with the regulations relating to share buybacks, VINCI SA (LEI:213800WFQ334R8UXUG83) declares the purchases of treasury shares below (FR0000125486), carried out from June 23rd to June 27th,2025: I - Aggregate presentation by day and by market Issuer’s nameDate of ...

COFACE SA: Disclosure of total number of voting rights and number of shares in the capital as at June 30, 2025 Paris, July 1st, 2025 – 17.45 Total Number of Shares Capital Theoretical Number of Voting Rights1 Number of Real Voting Rights2 150,179,792 150,179,792 149,327,732 (1) including own shares(2) excluding own shares Regulated documents posted by COFACE SA have been secured and authenticated with the blockchain technology by Wiztrust. You can check the authenticity on the website www.wiztrust ...